The rho-guanine nucleotide exchange factor domain of obscurin regulates assembly of titin at the Z-disk through interactions with Ran binding protein 9.
Obscurin is an approximately 800-kDa protein composed of structural and signaling domains that organizes contractile structures in striated muscle. We have studied the Rho-GEF domain of obscurin to understand its roles in morphogenesis and signaling. We used adenoviral overexpression of this domain, together with ultrastructural and immunofluorescence methods, to examine its effect on maturing myofibrils. We report that overexpression of the Rho-GEF domain specifically inhibits the incorporation of titin into developing Z-disks and disrupts the structure of the Z-disk and Z/I junction, and alters features of the A/I junction. The organization of other sarcomeric markers, including alpha-actinin, was not affected. We identified Ran binding protein 9 (RanBP9) as a novel ligand of the Rho-GEF domain and showed that binding is specific, with an apparent binding affinity of 1.9 microM. Overexpression of the binding region of RanBP9 also disrupted the incorporation of titin into developing Z-disks. Immunofluorescence localization during myofibrillogenesis indicated that the Rho-GEF domain assembles into sarcomeres before RanBP9, which first occurs in myonuclei and later in development translocates to the myoplasm, where it colocalizes with obscurin. Both the Rho-GEF domain and its binding region on RanBP9 bind directly to the N-terminal Ig domains of titin, which flank the Z-disk. Our results suggest that the Rho-GEF domain interacts with RanBP9 and that both can interact with the N-terminal region of titin to influence the formation of the Z-disk and A/I junction.
Bowman
Amber L
AL
Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Catino
Dawn H
DH
Strong
John C
JC
Randall
William R
WR
Kontrogianni-Konstantopoulos
Aikaterini
A
Bloch
Robert J
RJ
D000185:Actinin / Q000378:metabolism; D048868:Adaptor Proteins, Signal Transducing / Q000737:chemistry*; D000818:Animals; D064211:Connectin; D003598:Cytoskeletal Proteins / Q000737:chemistry*; D020558:GTP Phosphohydrolases / Q000378:metabolism; D005786:Gene Expression Regulation; D020662:Guanine Nucleotide Exchange Factors / Q000737:chemistry*; D008024:Ligands; D051379:Mice; D009124:Muscle Proteins / Q000737:chemistry*; D009687:Nuclear Proteins / Q000737:chemistry*; D011485:Protein Binding; D011494:Protein Kinases / Q000737:chemistry*; D017346:Protein Serine-Threonine Kinases; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry; D064067:Rho Guanine Nucleotide Exchange Factors; D020349:Surface Plasmon Resonance; D020798:Two-Hybrid System Techniques; D054460:rho-Associated Kinases / Q000378:metabolism*
D048868:Adaptor Proteins, Signal Transducing; D064211:Connectin; D003598:Cytoskeletal Proteins; D020662:Guanine Nucleotide Exchange Factors; D008024:Ligands; D009124:Muscle Proteins; D009687:Nuclear Proteins; C116005:Ran binding protein 9; D011994:Recombinant Proteins; D064067:Rho Guanine Nucleotide Exchange Factors; D000185:Actinin; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; C515766:obscn protein, mouse; D054460:rho-Associated Kinases; D020558:GTP Phosphohydrolases